A new series of benzimidazole, 1, 2, 4-triazole, and 1, 3, 5-triazine derivatives were
designed and synthesized using a microwave irradiation synthetic approach utilizing 2 …

This review covers article and patent data obtained mostly within the period 2013− 2023 on
the synthesis and biological activity of quinazolines [c]-annelated by five-and six-membered …

In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …

We use molecular modelling and pharmacological testing to identify TCM compounds that
may suppress SQS activity. By utilising previously established SQS inhibitors, ten HipHop …

Deregulation of various protein kinases is considered as one of the important factors
resulting in cancer development and metastasis, thus multi-targeting the kinase family is one …

This study represents the design and synthesis of a new set of triazole-coumarin-glycosyl
hybrids and their tetrazole hybrid analogues possessing various sugar moieties and …

Toxicity and resistance to newly synthesized anticancer drugs represent a challenging
phenomenon of intensified concern arising from variation in drug targets and consequently …

The observed toxicity of newly designed anticancer drugs is considered as an impediment
challenging phenomenon of intense concern arising from diversity in drug targets and the …

Breast cancer stands as the leading cause of cancer‐related deaths among women globally,
but current therapy is restricted to the serious adverse effects and multidrug resistance …

Triazoloquinazoline is a fused heterocyclic nucleus, formed by the fusion of two fundamental
heterocyclic moieties; triazole and quinazoline. This class of compound is known for its …